The COVID-19 vaccine developed by Oxford University and AstraZeneca is safe and produces an immune response in all adults, according to preparatory outcomes from a phase two trial.
The results declared in the Lancet medical journal on Thursday confirmed that the vaccine applicant was tested on 560 healthy adults and provoked a similar immune response among those aged between 18 and 55 and those over 56-years-old.
“We hope that this means our vaccine will help to protect some of the most vulnerable people in society, but further research will be needed before we can be sure,” Dr. Maheshi Ramasamy, a co-author of the study at the University of Oxford, said.
United States National Security Council (NSC) Coordinator for Strategic Communications John Kirby told Al-Jazeera on…
Tunis Court of Appeal confirms the verdict pronounced in the first instance against Ennahdha leader…
Spanish Prime Minister Pedro Sánchez stated on Friday that he would “reveal on Wednesday the…
A patrol affiliated with intelligence units in the National Guard district of Manouba was able…
A middle school in the locality of El Jadida, in the Manouba region, registered the poisoning…
Tabarka National Guard research and investigation brigade carried out a raid on a coral trafficker.…
This website uses cookies.